$ADMA News

Mizuho Maintains Outperform on ADMA Biologics, Lowers Price Target to $17

Adma Biologics (ADMA) Suffers a Larger Drop Than the General Market: Key Insights

Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?

BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell?

Is ADMA Stock's 13.5% Monthly Gain a Sign of Recovery?

Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider

Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know

Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors

ADMA Biologics (ADMA) Hit With Federal Securities Lawsuit Over Revenue Inflation Allegations

Adma Biologics (ADMA) Dips More Than Broader Market: What You Should Know

Adma Biologics (ADMA) Stock Dips While Market Gains: Key Facts

ADMA Biologics (ADMA) Valuation After 2026 Guidance Reset And BIVIGAM Headwinds

ADMA Biologics (ADMA) Receives FDA Label Expansion for ASCENIV

Is ADMA Biologics, Inc. (ADMA) Among the Best Russell 2000 Stocks to Invest In According to Hedge Funds?

ADMA Biologics: Longstanding Bull Hits The Reset Button After Murky Q1 Earnings

Can Asceniv Help ADMA Navigate the Current IG Market Challenges?

Is it Time to Exit ADMA Biologics Stock After a 22% Monthly Plunge?

How Channel Stuffing Probes and ASCENIV’s Pediatric Expansion Will Impact ADMA Biologics (ADMA) Investors

Here’s What Analysts Think About ADMA Biologics (ADMA)

Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?